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Abstract 
Solitary rectal ulcer syndrome (SRUS) is an uncommon disorder which can present in 
patients being evaluated for defecatory disorders or which can present as a primary 
process often involving hematochezia, rectal pain and tenesmus. Unfortunately the 
diagnosis of this disorder is often delayed due to misdiagnosis and/or physician 
unfamiliarity with the condition. We present a 24-year-old female who presented with 
6 months of bloody diarrhea and weight loss. She had been receiving treatment for a 
presumed diagnosis of inflammatory bowel disease (IBD) due to an endoscopic picture of 
rectal thickening, edema and ulceration and had been on prednisone for 2 months prior 
to presentation without relief of her symptoms. After further testing including repeat 
endoscopy with biopsies, defecography and anorectal manometry, the diagnosis of SRUS 
was made and treatment was changed. Medical management was unsuccessful and she 
ultimately required surgical intervention. This case highlights the difficulty in diagnosing 
SRUS due to its resemblance to other gastrointestinal diseases and should serve as a 
reminder that if a patient is not responding to IBD therapy, another etiology should be 
considered. 
 
Introduction 
Solitary rectal ulcer syndrome (SRUS) is an uncommon disorder, with a reported 
prevalence of 1:100,000 adults [1]. SRUS is characterized by symptoms such as 
hematochezia, rectal pain, rectal fullness and tenesmus. Additionally, SRUS can be 
asymptomatic and found secondarily in patients undergoing surgery for defecatory 
disorders such as rectal intussusception and rectal prolapse. The diagnostic tools used 
include anorectal manometry, defecography and endoscopy with biopsies of the affected 
area. Unfortunately, however, the diagnosis of SRUS is often significantly delayed, and in 
many studies the average time from onset of symptoms to diagnosis was between 4 and 
8 years [2–4]. This delay is likely due to the fact that SRUS can mimic other 
gastrointestinal conditions such as neoplasm and inflammatory bowel disease (IBD) [2].   
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We present a 24-year-old female with no prior gastrointestinal complaints who 
complained of 6 months of bloody diarrhea and weight loss. The patient had been given a 
diagnosis of IBD prior to presentation and had been receiving prednisone and a 5-ASA 
medication for 2 months with no relief of her symptoms. After testing she was diagnosed 
with SRUS and medical therapy was started. Unfortunately she continued to have 
difficulties with hematochezia and ultimately required surgical intervention which 
resolved her symptoms. 
Case Report 
A 24-year-old previously healthy female was seen in consultation for complaints of 6 months of 
bloody diarrhea. She was having between five and ten episodes daily with tenesmus and fecal urgency. 
There was no fecal incontinence. The stool was mixed with frank blood and clots and on occasions she 
would pass blood without stool. She had no prior history of gastrointestinal symptoms such as 
constipation or bloody stools. Her family history was notable for lymphoma and the absence of IBD or 
other gastrointestinal conditions. Also noted was a 15-pound weight loss since the onset of her 
symptoms accompanied by fatigue and malaise. She denied fevers or chills and remainder of review of 
systems was negative. 
Prior to being seen in our clinic, she had undergone colonoscopy elsewhere that noted an ulcerated, 
‘apple-core’ lesion at 10 cm from the rectal verge. Biopsies were interpreted as ulceration consistent with 
an inflammatory polyp; no dysplasia was seen. The remainder of the colon was normal. She was then 
prescribed oral mesalamine as well as cortisone enemas as treatment for IBD. These therapies did not 
improve her symptoms and she was ultimately started on prednisone 20 mg p.o. b.i.d. She had been on 
steroids for approximately two months with no improvement before presentation to our institution. 
We repeated a colonoscopy showing her rectum to contain pseudopolyps within a nodular, friable, 
ulcerated rectal mucosa extending from 5 to 10 cm from the anal verge (fig. 1). Endoscopic ultrasound 
of the affected area was performed and showed that the area was hypoechoic and diffusely thickened to 
the muscularis propria. Anorectal manometry was performed which showed no evidence for pelvic floor 
dyssynergia, but evidence of rectal hypersensitivity was present. A defecating proctogram was 
performed which showed a nodular prominence posteriorly overlying the sling musculature measuring 
approximately 2 cm in diameter. This segment appeared to prolapse out of the anal opening on 
evacuation. Colonoscopic biopsies showed eroded hyperplastic mucosa with fibromuscularization of the 
lamina propria and hyperplastic glandular changes (fig. 2), findings consistent with SRUS. 
Prednisone was discontinued and topical management initiated with hydrocortisone foam and 
sucralfate enemas. Cholestyramine was used to control her diarrhea. She continued to bleed, however, 
and required outpatient blood transfusion. Ultimately she was referred to colorectal surgery where a 
rectopexy was performed. After 8 months of follow-up she was doing well without recurrence of her 
symptoms. 
Discussion 
SRUS is an uncommon disorder; one study cited an incidence of 1:100,000 adults [1]. 
It is largely a disorder of younger adults, more than 80% of patients in the literature are 
under the age of 50. The name of this disorder is in itself misleading, since often the 
lesions are neither solitary nor ulcerated. Most lesions occur on the anterior rectal wall 
within 10 cm of the anal verge. The most common presenting symptoms are rectal 
bleeding, straining and altered bowel habits. Often a careful history will elicit prior 
symptoms of constipation and/or description of rectal prolapse. SRUS is unfortunately a 
disorder that often goes undiagnosed for prolonged periods of time due to misdiagnosis 
and lack of awareness of the condition by physicians. Tjandra et al. [2] examined 98 
patients with SRUS and found that 26% of them had been initially misdiagnosed, with a 
median duration of incorrect diagnosis of 5 years. The most common misdiagnoses were  
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IBD and neoplasm. Nearly one-third of these patients had been on high doses of 
prednisone for more than 3 months prior to SRUS diagnosis. 
The diagnosis of SRUS is made using a combination of diagnostic tools including a 
careful history and physical exam in concert with endoscopy and biopsy. Anorectal 
manometry and defecography will often be obtained to support the diagnosis and/or to 
understand the etiology of the patient’s symptoms. Endoscopy can reveal a large variety of 
findings extending from mild mucosal erythema to multiple, large ulcerations in the 
rectum. These ulcers can measure up to 4 cm but usually are less than 1.5 cm. Polypoid 
lesions have also been observed [5]. Histology is important in making a correct diagnosis 
of SRUS. Characteristic microscopic findings include the presence of mucosal 
architectural distortion without inflammation; this lack of inflammation differentiates 
SRUS from IBD. Additionally obliteration of the lamina propria with fibromuscular tissue 
is a hallmark of SRUS. Defecography can reveal rectal intussusception and/or prolapse. 
Anorectal manometry is performed to evaluate for concomitant or other defecatory 
disorders such as dyssynergic defecation. 
The pathogenesis of SRUS is poorly and incompletely understood. It is thought that a 
combination of rectal prolapse and paradoxical puborectalis contraction leads to the 
generation of high pressures within the rectum, leading to ischemia and, ultimately, 
ulceration. Additionally, paradoxical puborectalis contraction creates shear forces on the 
rectal mucosa, and this is thought to be another etiologic factor in this disorder. These are 
simply theories, however, as not all patients with SRUS have evidence of paradoxical 
contraction and there have been cases where correction of rectal prolapse does not resolve 
the symptoms, leading to a supposition that rectal prolapse is not a causative but rather a 
concomitant process associated with SRUS. 
Treatment of the SRUS includes medical, surgical and behavioral options. Medical 
therapeutic options include systemic and topical medications such as corticosteroid and 
sucralfate enemas [6, 7], human fibrin sealant [8] and sulfasalazine, both orally and 
topically [9, 10]. 
Biofeedback has shown some success in SRUS. Biofeedback improves coordination of 
the pelvic musculature in combination with anal relaxation techniques to minimize the 
shear stress and potential for ischemia in the rectum that was due to dyssynergic 
defecation. Rao et al. [11] performed a prospective trial of biofeedback therapy in 
11 patients with medically refractory SRUS. In this population, 82% of patients showed 
evidence of pelvic dyssynergia as well as higher anal pressures and lesser anal relaxation 
with straining compared to a population of 15 healthy controls. After a 12-week period of 
biofeedback therapy, none of these patients re-demonstrated dyssynergic defecation, and 
anal residual pressures and percentage of anal relaxation both significantly decreased. On 
repeat endoscopic evaluation, 54% of patients had ≥50% ulcer healing. Biofeedback has 
also been shown to improve rectal blood flow via Doppler mucosal flowmetry, and this 
improvement was correlated with subjective improvement in symptoms and endoscopic 
improvement in ulceration [12]. 
Unfortunately not all patients respond to medical or behavioral intervention and some 
will require surgical intervention. Common surgical techniques include transabdominal 
rectopexy, Delorme procedure (transrectal mucosal stripping with mucosectomy), low 
anterior resection and occasionally colostomy. Choi et al. [13] reviewed 49 patients with 
histopathologically diagnosed SRUS and found postoperative symptomatic improvement 
in approximately 70% of patients. Transabdominal rectopexy and perineal 
rectosigmoidectomy comprised the majority of surgical procedures performed in this  
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series. In another series involving 66 patients undergoing surgery for SRUS, rectopexy 
was the predominant technique performed with a success rate of approximately 55%. This 
study also identified fecal incontinence and inability to complete evacuation as 
preoperative predictors of poor surgical outcome [3]. Other retrospective studies have 
been performed with similar results, and it is usually recommended that patients undergo 
a trial of medical management before undergoing surgery [14]. 
Conclusion 
SRUS is an uncommon disorder which is often mistaken for other conditions such as 
IBD or neoplasm. The diagnosis of SRUS can be significantly delayed. Medical, surgical 
and behavioral therapies have all been used and it is generally accepted that before 
proceeding to surgery, patients undergo a trial of medical and, if appropriate, behavioral 
therapy in the form of biofeedback. Topical therapies include glucocorticoids, sucralfate 
and mesalamine compounds; however efficacy is limited. If evidence of dyssynergic 
defecation is present, biofeedback has shown promising results. Physicians should be 
aware of this diagnosis, especially in patients who are not improving with conventional 
therapies directed towards IBD. 
 
 
 
 
 
Fig. 1. Endoscopic appearance of an approximately 5 cm area within the rectum showing pseudopolyps 
within a nodular, edematous, ulcerated mucosa. 
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Fig. 2. Pathology showing eroded hyperplastic mucosa with fibromuscularization of the lamina 
propria and hyperplastic glandular changes. 
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